NCT05729191View on ClinicalTrials.gov

Evaluation of the Acceptance of the Anti-COVID-19 Vaccine Offer Among Pregnant Women

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

March 30, 2022

Study Completion Date

March 30, 2022

Conditions
Pregnant WomenCOVID 19 VaccineVaccination Hesitancy
Interventions
BIOLOGICAL

Anti Covid 19 vaccination campaign for pregnat women

Assessment of vaccine hesitancy and Covid-19 disease knowledge

Trial Locations (1)

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05729191 - Evaluation of the Acceptance of the Anti-COVID-19 Vaccine Offer Among Pregnant Women | Biotech Hunter | Biotech Hunter